Initial general form for registration of a class of securities pursuant to Section 12(g)

Summary of Statement of Operations Acquisition (Details)

v3.21.4
Summary of Statement of Operations Acquisition (Details) - USD ($)
 3 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Business Acquisition [Line Items]        
Net Revenues $ 129,426
General and Administrative expenses 379,530 2,245 507,768 17,913
Depreciation and amortization 48,637    
Total Operating Expenses 525,809 4,410 507,768 17,913
Loss from Operations (396,383) (4,410) (507,768) (17,913)
Other (Expense) 100,023
Net Loss $ (296,360) $ (4,410) $ (507,768) $ (17,913)
Basic and Diluted (loss) per share $ (0.00) $ (0.00) $ (0.00) $ (0.00)
Basic and Diluted weighted average common shares outstanding 234,953,286 249,418,545 249,220,391 249,418,545
Rennova Health Inc [Member]        
Business Acquisition [Line Items]        
Net Revenues   $ 174,941 $ 493,621  
Direct costs of revenues   390 7,166  
General and Administrative expenses   300,675 1,343,436  
Depreciation and amortization   48,400 195,055  
Total Operating Expenses   349,465 1,545,657  
Loss from Operations   (174,524) (1,052,036)  
Other (Expense)   (42,103)  
Net Loss   $ (174,524) (1,094,139)  
Net loss attributed to common stockholders     $ (1,861,639)  
Basic and Diluted (loss) per share   $ (0.00) $ (0.00)  
Basic and Diluted weighted average common shares outstanding   234,953,286 234,953,286